Testosterone cream prescribed to women primarily improves sexual desire and satisfaction, particularly in postmenopausal women experiencing a persistent, distressing loss of libido. While testosterone is often thought of as a male hormone, women naturally produce it too, and levels decline with age. When applied to the skin in small doses, testosterone cream can restore some of what’s been lost, with effects on desire, arousal, mood, energy, and more.
Why Women Use Testosterone Cream
The main reason doctors prescribe testosterone cream for women is a condition called hypoactive sexual desire disorder, or HSDD. This is more than a temporary dip in libido. It’s a persistent absence of sexual desire that causes real personal distress. It’s common after menopause, whether that happened naturally or through surgery such as a hysterectomy with removal of the ovaries.
A 2019 global consensus statement from multiple medical societies concluded that HSDD in postmenopausal women is the only evidence-based reason to prescribe testosterone to women. There isn’t enough data to formally recommend it for premenopausal women or for other conditions like fatigue or bone loss on its own, though some practitioners prescribe it off-label for broader menopausal symptoms.
Effects on Sexual Function
The strongest evidence for testosterone cream in women centers on sexual health. Multiple large randomized trials have consistently found that a daily transdermal dose increases the frequency of satisfying sexual experiences, desire, arousal, orgasms, and overall sexual responsiveness, while reducing sexual distress. On average, women using testosterone cream experienced roughly one additional satisfying sexual event per month compared to placebo. That may sound modest, but for women who had essentially lost all desire, it represents a meaningful shift.
In one study of naturally menopausal women, testosterone cream increased sexual desire scores significantly within the first five weeks, with continued improvement through 24 weeks. The number of orgasms and total sexual activity also rose. Another trial found a 67% increase in sexual desire at 24 weeks. Importantly, these benefits held up across studies of both women who had gone through natural menopause and those who had surgical menopause, and the improvements occurred whether or not the women were also taking estrogen therapy.
Effects Beyond the Bedroom
Many women report improvements that go well beyond libido. Commonly described benefits include better mood, sharper concentration, more motivation, and higher energy levels. These effects are harder to measure in clinical trials than sexual outcomes, so the formal evidence is thinner, but the pattern is consistent in clinical practice.
Testosterone also plays a role in maintaining bone density and muscle mass in women. When combined with estrogen as part of hormone replacement therapy, it has been shown to improve bone density and enhance cognitive performance. Some women with low testosterone experience unexplained fatigue, depressed mood, brain fog, and decreased muscle strength. These symptoms overlap heavily with general menopause symptoms, which is one reason it can be difficult to tease apart what testosterone alone is doing versus what estrogen or other factors contribute.
How It’s Applied
Testosterone cream for women is applied to the skin, typically on the shoulders, upper arms, or abdomen, once daily. The dose is a fraction of what men use. Standard male formulations start at 40 to 50 milligrams per day, while women generally use doses around 5 to 10 milligrams daily, aiming to bring testosterone levels into the normal premenopausal range rather than above it.
One important practical concern is skin-to-skin transfer. The cream can rub off onto other people or pets through close contact, which matters most for young children and female partners. Covering the application site with clothing after it dries and washing hands thoroughly after applying reduces this risk. Transfer to a male partner is considered minimal.
No FDA-Approved Product for Women
There is no FDA-approved testosterone product for women in the United States. The FDA declined to approve a transdermal testosterone patch for women back in 2004, citing a lack of long-term safety data. Australia remains the only country with an approved female testosterone product. In practice, doctors in the U.S. prescribe testosterone cream off-label, often through compounding pharmacies that prepare lower-dose formulations tailored to women.
This off-label status doesn’t mean the treatment is experimental or unsupported. It means no pharmaceutical company has completed the specific regulatory process required for female approval. The clinical evidence supporting its use for HSDD is robust and rated at the highest evidence level by international medical societies.
Monitoring and Timeline
Before starting testosterone cream, your doctor should check your baseline testosterone level with a blood test. A follow-up blood test is recommended 3 to 6 weeks after starting treatment, then every 6 months after that. These checks ensure your levels stay within the normal female range and help catch signs of overuse early.
Most women begin to notice effects within the first several weeks, though full benefits may take up to 24 weeks. If you haven’t noticed any improvement by 6 months, guidelines recommend stopping treatment. Long-term safety data currently extends only to about 24 months of use, so ongoing conversations with your prescriber about risks and benefits are part of the process.
Possible Side Effects
At appropriate doses, side effects are generally mild. The most common concern is androgenic effects: acne, increased facial hair growth, or oily skin. These are signs that testosterone levels may be climbing too high, which is why regular blood monitoring matters. Lowering the dose or stopping treatment typically reverses these changes.
More serious concerns, like voice deepening or scalp hair thinning, are rare at physiologic female doses but can occur with prolonged overuse. The relationship between testosterone and breast cancer has been studied, and current evidence does not show an increased risk at normal female doses, though data beyond two years is limited.